Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Lymphoma 13Hodgkin Disease 12Teratoma 6Testicular Neoplasms 4Endodermal Sinus Tumor 4Carcinoma, Embryonal 3Testicular Germ Cell Tumor 2Seminoma 2Ovarian Germ Cell Cancer 2Neoplasm Metastasis 2Cardiotoxicity 2Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Teratoma, Testicular 1Sertoli-Leydig Cell Tumor 1Pleural Effusion, Malignant 1Ovarian gynandroblastoma 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Neoplasms, Germ Cell and Embryonal 1Multiple Myeloma 1Mediastinal Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1HIV Infections 1Granulosa cell tumor of the ovary 1

Interventions

Paclitaxel 2etoposide phosphate 1Taxes 1Platinum 1Cisplatin 1Carboplatin 1Bleomycin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Sertoli-Leydig Cell Tumor × Bleomycin × Clear all
NCT01042522 2022-01-25

Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors

GOG Foundation

Phase 2 Unknown
63 enrolled 16 charts
Gynecologic

Granulosa cell tumor of the ovary, Ovarian gynandroblastoma, Sertoli-Leydig Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡